LCM
EBS icon

Laurion Capital Management’s Emergent Biosolutions EBS Stock Holding History

Laurion Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,302
Closed -$132K – 394
2024
Q2 		$132K Buy
+19,302
New +$83.1K ﹤0.01% 500
2023
Q4 		– Sell
-11,012
Closed -$37.4K – 512
2023
Q3 		$37.4K Buy
+11,012
New +$61K ﹤0.01% 468
2019
Q4 		– Sell
-7,200
Closed -$376K – 967
2019
Q3 		$376K Buy
+7,200
New +$335K ﹤0.01% 819
2017
Q3 		– Sell
-6,311
Closed -$214K – 1644
2017
Q2 		$214K Buy
+6,311
New +$195K ﹤0.01% 1528

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return